Wednesday, September 16, 2026Latest filing Sep 14, 2026

GNPX Congressional Stock Trades

Genprex, Inc. - Common Stock (GNPX)

Last disclosed trade Feb 5

Every disclosed trade in GNPX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Tim Moore · Bought $GNPX · Oct 29 · $15K–$50K

0.55MED
Disclosure speedx 0.250.60
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.350.77

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $GNPX

Get notified when any member of Congress trades $GNPX. Free, no card, no spam.

Follow free →
4
Disclosed trades
4
Buys
0
Sells
1
Members trading

The record on $GNPX

Coldpine has parsed 4 disclosed trades in $GNPX by 1 member of Congress, drawn from 4 periodic transaction reports dated Oct 29, 2025 through Feb 5, 2026. All of them came from House members, all filed by Republicans.

Of the 4 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 18 days. The longest was 25 days: a $GNPX purchase by Tim Moore dated Nov 7, 2025, disclosed Dec 2, 2025. How late filing is measured across all of Congress is in the late-filers study.

Members who trade GNPX

Recent disclosed trades in GNPX

DateMemberTypeAmount
Feb 5Tim Moore(NC)buy$1K–$15K
Dec 18Tim Moore(NC)buy$1K–$15K
Nov 7Tim Moore(NC)buy$1K–$15K
Oct 29Tim Moore(NC)buy$15K–$50K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →